Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Maggio

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Biochemistry|June 1, 2000
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanismW P Esler, E R Stimson, J M Jennings, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 20, 2015
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuseC E Van Skike, S E Maggio, A R Reynolds, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Substance P receptor binding sites are expressed by glia in vivo after neuronal injuryP W Mantyh, D J Johnson, C G Boehmer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 1, 1995
Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and humanP W Mantyh, S D Rogers, C J Allen, et al.
Neuroscience|April 1, 1993
Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterizationC J Allen, J R Ghilardi, S R Vigna, et al.
Nature Biotechnology|March 1, 1997
A beta deposition inhibitor screen using synthetic amyloidW P Esler, E R Stimson, J R Ghilardi, et al.
Peptides|November 1, 1988
Substance P and substance K receptor binding sites in the human gastrointestinal tract: localization by autoradiographyT S Gates, R P Zimmerman, C R Mantyh, et al.
Brain Research|February 12, 1999
Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42)E O'Hare, D T Weldon, P W Mantyh, et al.
Drug and Alcohol Dependence|November 2, 2018
An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDISarah E Maggio, Meredith A Saunders, Kimberly Nixon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn diseaseC R Mantyh, T S Gates, R P Zimmerman, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Biochemistry|June 1, 2000
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanismW P Esler, E R Stimson, J M Jennings, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 20, 2015
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuseC E Van Skike, S E Maggio, A R Reynolds, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Substance P receptor binding sites are expressed by glia in vivo after neuronal injuryP W Mantyh, D J Johnson, C G Boehmer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 1, 1995
Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and humanP W Mantyh, S D Rogers, C J Allen, et al.
Neuroscience|April 1, 1993
Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterizationC J Allen, J R Ghilardi, S R Vigna, et al.
Nature Biotechnology|March 1, 1997
A beta deposition inhibitor screen using synthetic amyloidW P Esler, E R Stimson, J R Ghilardi, et al.
Peptides|November 1, 1988
Substance P and substance K receptor binding sites in the human gastrointestinal tract: localization by autoradiographyT S Gates, R P Zimmerman, C R Mantyh, et al.
Brain Research|February 12, 1999
Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42)E O'Hare, D T Weldon, P W Mantyh, et al.
Drug and Alcohol Dependence|November 2, 2018
An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic α6β2* antagonist r-bPiDISarah E Maggio, Meredith A Saunders, Kimberly Nixon, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn diseaseC R Mantyh, T S Gates, R P Zimmerman, et al.
Pageof 10